Reporting person on SEC Form 4

Shalabh K. Gupta

Shalabh K. Gupta is CEO at Unicycive Therapeutics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 15, 2026, each linked to the official Form 4.

CEO

Disclosures on record

1

Companies involved

1

Disclosure history

Unicycive TherapeuticsUNCY
May 14, 2026762Kdisclosed Jun 15
Details Official record